Optimizing the management of renal anemia: challenges and new opportunities

This publication has 45 references indexed in Scilit:

• Epoetin delta, erythropoietin produced in a human cell line, in the management of anaemia in predialysis chronic kidney disease patients
  Current Medical Research and Opinion, 2007
• The prevalence of anemia in patients with chronic kidney disease
  Current Medical Research and Opinion, 2004
• Anaemia in haemodialysis patients of five European countries: association with morbidity and mortality in the Dialysis Outcomes and Practice Patterns Study (DOPPS)
  Nephrology Dialysis Transplantation, 2004
• Differentiating Factors Between Erythropoiesis-Stimulating Agents
  Drugs, 2004
• Epoetin alpha and beta in their erythropoetin isoform compositions and biological properties
  British Journal of Haematology, 1998
• Structures of sialylated oligosaccharides of human erythropoietin expressed in recombinant BHK‐21 cells
  European Journal of Biochemistry, 1993
• Correction of the Anemia of End-Stage Renal Disease with Recombinant Human Erythropoietin
  New England Journal of Medicine, 1987
• EFFECT OF HUMAN ERYTHROPOIETIN DERIVED FROM RECOMBINANT DNA ON THE ANAEMIA OF PATIENTS MAINTAINED BY CHRONIC HAEMODIALYSIS
  The Lancet, 1986
• Human erythropoietin gene: high level expression in stably transfected mammalian cells and chromosome localization.
  Proceedings of the National Academy of Sciences, 1986
• Cloning and expression of the human erythropoietin gene.
  Proceedings of the National Academy of Sciences, 1985